⌘K

Login Start Free

Home/Companies/CIK 0001974915

V

ISSUER//CIK 0001974915

Vestal Point Capital, LP

other

Exchange

—

Entity type

other

Fiscal year end

Dec 31

Headquarters

DE

Recent Filings

10 items

SCHEDULE 13G/A
Black Diamond Therapeutics, Inc.
Feb 17, 4:09 PM ET·0000902664-26-001085
10.9 KB
SCHEDULE 13G
Solid Biosciences Inc.
Feb 17, 4:08 PM ET·0000902664-26-001082
14.9 KB
SCHEDULE 13G
Taysha Gene Therapies, Inc.
Feb 17, 4:07 PM ET·0000902664-26-001081
14.9 KB
SCHEDULE 13G
Enliven Therapeutics, Inc.
Feb 17, 4:07 PM ET·0000902664-26-001079
15.3 KB
SCHEDULE 13G
CRESCENT BIOPHARMA, INC.
Feb 17, 4:06 PM ET·0000902664-26-001077
16.4 KB
SCHEDULE 13G
Arcellx, Inc.
Feb 17, 4:05 PM ET·0000902664-26-001076
14.7 KB
SCHEDULE 13G
Alto Neuroscience, Inc.
Feb 17, 4:05 PM ET·0000902664-26-001074
14.8 KB
13F-HR
Vestal Point Capital, LP
Feb 17, 4:01 PM ET·0001974915-26-000002
44.0 KB
SCHEDULE 13G/A
uniQure N.V.
Nov 14, 4:08 PM ET·0000902664-25-005007
11.0 KB
SCHEDULE 13G
TENAX THERAPEUTICS, INC.
Nov 14, 4:07 PM ET·0000902664-25-005003
18.0 KB

Insiders

0

No insiders on record

Tickers

No tickers on record

Addresses

business
632 BROADWAY SUITE 602
NEW YORK, NY, 10012
mailing
632 BROADWAY SUITE 602
NEW YORK, NY, 10012